Elias Rackl, Anne Hartz, Hazal Aslan Rejeski, Lin Li, Lara Kristina Klauer, Selda Ugur, Elena Pepeldjiyska, Carina Amend, Melanie Weinmann, Fatemeh Doraneh-Gard, Julian Stein, Nina Reiter, Corinna L Seidel, Caroline Plett, Daniel Christoph Amberger, Peter Bojko, Doris Kraemer, Jörg Schmohl, Andreas Rank, Christoph Schmid, Helga Maria Schmetzer
T-cell receptor gamma delta (TCRγδ) expressing T-cells are known to mediate an MHC-independent immune response and could therefore qualify for immune therapies. We examined the influence of dendritic cells(DC)/antigen presenting cell (APC) generated from blast-containing whole blood (WB) samples from AML and MDS patients on the provision of (leukemia-specific) TCRγδ expressing T-cells after mixed lymphocyte culture (MLC). Kit-M (granulocyte-macrophage colony-stimulating factor (GM-CSF) + prostaglandin E1 (PGE1)) or Kit-I (GM-CSF + Picibanil) were used to generate leukemia derived APC/DC (DCleu )from WB, which were subsequently used to stimulate T-cell enriched MLC...
September 20, 2024: Molecular Immunology